prednisolone-hemisuccinate and Pancreatic-Diseases

prednisolone-hemisuccinate has been researched along with Pancreatic-Diseases* in 1 studies

Other Studies

1 other study(ies) available for prednisolone-hemisuccinate and Pancreatic-Diseases

ArticleYear
[Prednisolone as a calcification inhibitor--a calciphylactic experiment in the rat pancreas].
    Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten, 1983, Volume: 43, Issue:3

    In the experimental situation the inhibitory potency of prednisolone on soft tissue calcification is confirmed. This glucocorticoid was locally applied prior to the commencement of a mastocalciphylactic experiment (Selye). Dosage: 10 mg per animal, body mass 150-180 g. In 16 out of 17 female rats there were no calcified deposits in the interstitium of the pancreas but in nearly all of the control animals a typical calciphylactic reaction could be found. It is suggested that glucocorticoids act by alteration of pancreatic mast cells.

    Topics: Animals; Calcinosis; Female; Pancreas; Pancreatic Diseases; Prednisolone; Rats; Rats, Inbred Strains

1983